Targeting MCM2 function as a novel strategy for the treatment of highly malignant breast tumors.
about
Minichromosome maintenance protein 2 and 3 promote osteosarcoma progression via DHX9 and predict poor patient prognosis.MCM10 overexpression implicates adverse prognosis in urothelial carcinoma.RETRACTED: Ablation of MCM10 using CRISPR/Cas9 restrains the growth and migration of esophageal squamous cell carcinoma cells through inhibition of Akt signaling.Subcellular localization of MCM2 correlates with the prognosis of ovarian clear cell carcinoma.
P2860
Targeting MCM2 function as a novel strategy for the treatment of highly malignant breast tumors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Targeting MCM2 function as a n ...... ighly malignant breast tumors.
@ast
Targeting MCM2 function as a n ...... ighly malignant breast tumors.
@en
type
label
Targeting MCM2 function as a n ...... ighly malignant breast tumors.
@ast
Targeting MCM2 function as a n ...... ighly malignant breast tumors.
@en
prefLabel
Targeting MCM2 function as a n ...... ighly malignant breast tumors.
@ast
Targeting MCM2 function as a n ...... ighly malignant breast tumors.
@en
P2093
P2860
P356
P1433
P1476
Targeting MCM2 function as a n ...... ighly malignant breast tumors.
@en
P2093
Futoshi Akiyama
Kouhei Yamamoto
Masanobu Kitagawa
Morito Kurata
Shiho Abe-Suzuki
Shinya Abe
P2860
P304
34892-34909
P356
10.18632/ONCOTARGET.5408
P407
P577
2015-09-30T00:00:00Z